Patents Assigned to MTM Research LLC
  • Publication number: 20120076777
    Abstract: The present invention is directed to compositions and methods targeting tissue resident cells, such as fibroblasts, in a subject harboring conditions or at risk for conditions that would benefit from anti-fibroblastic therapy. The present invention relates to the use of fluorochemical compositions and methods of delivery that result in retention of the fluorochemical composition and any bioactive agent delivered in combination with the fluorochemical composition.
    Type: Application
    Filed: July 1, 2011
    Publication date: March 29, 2012
    Applicant: MTM Research LLC
    Inventor: Matthew T. McLeay